Sunil Healthcare (NSE:SUNLOC) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNLOC Sunil Healthcare Ltd NSE:SUNLOC
48 GF Score
Price ₹68.00
GF Value ₹66.99
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare 5-Year Yield-on-Cost %?

Sunil Healthcare NSE:SUNLOC -0.56% 48 5-Year Yield-on-Cost % is 0.00 as of Aug. 21, 2026. GuruFocus rates NSE:SUNLOC with a GF Score™ of 48/100 and a GF Value™ of ₹66.99 (Fairly Valued). The stock has 7 warning signs investors should review. Among 507 Drug Manufacturers companies, Sunil Healthcare ranks worse than 197238.46% on this metric.

Sunil Healthcare's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Sunil Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:



NSE:SUNLOC's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.36
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Sunil Healthcare  (NSE:SUNLOC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sunil Healthcare 5-Year Yield-on-Cost % Related Terms


NSE:SUNLOC vs : 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunil Healthcare 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sunil Healthcare's 5-Year Yield-on-Cost % falls into.


NSE:SUNLOC
48GF Score
Sunil Healthcare Ltd NSE:SUNLOC
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sunil Healthcare is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Sunil Healthcare (NSE:SUNLOC) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sunil Healthcare and its competitors. According to the industry distribution chart, Sunil Healthcare ranks #999999 out of 507 companies in the Drug Manufacturers industry.
Is Sunil Healthcare's 5-Year Yield-on-Cost % too high?
Sunil Healthcare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Sunil Healthcare ranks #999999 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sunil Healthcare has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's 5-Year Yield-on-Cost % compare to ?
According to the Drug Manufacturers industry distribution chart, Sunil Healthcare ranks #999999 out of 507 companies for 5-Year Yield-on-Cost %. This places Sunil Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.36, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sunil Healthcare and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunil Healthcare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (NSE:SUNLOC) is currently considered Fairly Valued. The stock's GF Value™ is ₹66.99, compared to a current price of ₹68.00 — trading 1.5% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Sunil Healthcare's overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sunil Healthcare (NSE:SUNLOC), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunil Healthcare (NSE:SUNLOC) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued. The current stock price of ₹68.00 is trading 1.5% above its estimated GF Value™ of ₹66.99. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for NSE:SUNLOC:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: ₹66.99 vs. price of ₹68.00 (1.5% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the NSE:SUNLOC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunil Healthcare Business Description

Comparable Companies
Other Exchanges 537253:India
Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
48GF Score

Get the complete analysis for NSE:SUNLOC

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price
₹66.99
GF Value